News
Universities across the country are scrambling to understand the implications of generative A.I.’s transformation of ...
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...
Aprilynne Alter‘s workshop on YouTube intros packed the room beyond capacity at the Friday session at VidCon 2025. The moment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results